
|Articles|April 17, 2013
Christine Solberg Strahl, PharmD, Discusses the Management of New Drugs on the Medical Benefit
Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction.
Advertisement
Christine Solberg Strahl, PharmD, Specialty Pharmacy Program Manager, HealthPartners, says that by managing specialty drugs before utilization patterns are established there is less member and provider dissatisfaction. Using medical injectables as an example, Dr Strahl says that there are coding and pricing issues associated when managing new specialty drugs that are administered on the specialty benefit.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
2
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
3
emtelligent Turns Unstructured Clinical Data Into Actionable Insights
4
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
5




